Jennifer B. Lai

Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population

Julia L. Marcus, Leo B. Hurley, Scott Chamberland et al. · Public Health Reports · 2018 · 77 citations · Full text

Public Health, Health Sciences, Epidemiologic Methods +13

Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health System

Jennifer B. Lai, M.A. Witt, Mary Patricia Pauly et al. · Drugs · 2017 · 24 citations

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +12

Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals

Jennifer O. Lam, Leo B. Hurley, Jennifer B. Lai et al. · Cancer Epidemiology Biomarkers & Prevention · 2021 · 19 citations · Full text

Medicine, Infectious Diseases, Oncology +15

Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system

Jennifer O. Lam, Leo B. Hurley, Scott Chamberland et al. · International Journal of STD & AIDS · 2019 · 16 citations · Full text

Pharmacy, Health Policy, Insurance +16

No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients

Julia L. Marcus, Leo B. Hurley, Scott Chamberland et al. · Clinical Gastroenterology and Hepatology · 2018 · 13 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +10